Gainesville / Coughlin / Houston / Hercules / Chelsea / Winooski / Lee / San Diego / San Jose / St. Louis / Arlington / Santa Cruz / /
Company
Hoover / Susin SA / III Radiation Therapy Oncology Group / Rosenthal SA / Amersham / GE / Wiley InterScience / Becton Dickinson / Leibel SA. / Bio-Rad / 2008 Wiley-Liss Inc. / / /
Event
Product Issues / /
Facility
University of Texas MD Anderson Cancer Center / University of Florida / University of Florida College / /
IndustryTerm
apoptotic machinery / treatment of prostate cancer / cancer therapeutics / nonvolatile aqueous chlorination products / therapy for localized prostate cancer / treatment of radiation resistant prostate cancer / energy / ultimate solution / propidium iodide solution / therapy for clinically localized prostate cancer / chemical perspective / treatment of numerous cardiovascular and metabolic disorders / /
MedicalCondition
improved prostate cancer / JE / PTEN wild-type and mutant human prostate cancer / advanced human tumors / both human prostate cancer / cultured human prostatic cancer / Neo (B) prostate cancer / human prostatic tumors / numerous cardiovascular and metabolic disorders / prostatic cancer / post radiation therapy prostate cancer / several human cancer / prostate cancer / resistant prostate cancer / MS / Rosen I. Prostate cancer / tumor / MELAS / prostate tumor / Cancer / tumors / disease / localized radio-naive prostate carcinoma / both wild-type and null p53 prostate cancer / congenital lactic acidosis / Locally recurrent prostate tumors / high risk prostate cancer / localized prostate cancer / unfavorable prognosis carcinoma / lactic acidosis / hereditary lactic acidosis disorders / human prostate cancer / prostate tumors / localized radio-recurrent prostate carcinoma / prostate carcinoma / /
DCA administration / Department of Urology / Florida Department / Florida College / American Cancer Society / University of Florida / University of Texas / /
Person
Lopez Torecilla / Lino Cutajar / Huang Z. Overcoming / Timothy McDonnell / Charles J. Rosser / /
The Prostate Dichloroacetate (DCA) Sensitizes BothWild-Type and Over Expressing Bcl-2 Prostate Cancer Cells InVitro to Radiation Wengang Cao,1,3 Saif Yacoub,1,3 Kathleen T. Shiverick,2,3